George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
11
3
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Influence of Finishing Clear Aligner Marginal Termination Design on Subgingival Periodontal Microbiota During Orthodontic Treatment: A Split-Mouth Study.
Role: lead
Process-Based Psychological Processes in Alcohol Use Disorder: A Case-Control Study Using PBAT, PHQ-9, and GAD-7
Role: lead
Longitudinal Evaluation of Short-Chain Fatty Acid Profiles During the Natural Disease Course and a Mediterranean Diet Intervention in Amyotrophic Lateral Sclerosis Patients
Role: lead
Robotic Medial Congruent Vs. Conventional Medial Pivot TKA
Role: lead
Oral Health and Dental Caries Prevention Intervention for Children in Romania
Role: collaborator
Feasibility of 3D Printed Models of Aortic Stenosis in Guiding TAVI Procedure
Role: collaborator
CCTA Coronary Hemodynamics, Systemic Inflammation and Vulnerable Plaques (COHESIVE)
Role: collaborator
Assessment of Lesion-Associated Myocardial Ischemia Based on Fusion Coronary CT Imaging
Role: collaborator
Impact of Cardiac Rehabilitation Programs on Left Ventricular Remodeling After Acute Myocardial Infarction - the REHAB Trial
Role: collaborator
Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling
Role: collaborator
Diffusion-tensor Imaging in Brain Tumors Evaluation
Role: lead
All 11 trials loaded